Carole J. Spangler

Corporate Officer/Principal at Clario Medical Imaging, Inc.

Health Technology

Consumer Services

Profile

Carole Spangler is Head of Sales for Clario Medical Imaging, Inc. Previously, she was Director of Business Development for Dendreon Corp.
She is an Adjunct Professor at the School of Business and Economics at Seattle Pacific University.
Dr. Spangler received an MBA from the University of Washington and a PhD from the Johns Hopkins University.

Carole J. Spangler active positions

Companies	Position	Start
Clario Medical Imaging, Inc. Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA.	Corporate Officer/Principal	-

All active positions of Carole J. Spangler

Former positions of Carole J. Spangler

Companies	Position	End
DENDREON CORPORATION	Corporate Officer/Principal	-

See the detail of Carole J. Spangler's experience

Training of Carole J. Spangler

The Johns Hopkins University	Doctorate Degree
University of Washington	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carole J. Spangler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Clario Medical Imaging, Inc. Clario Medical Imaging, Inc. Medical SpecialtiesHealth Technology Clario Medical Imaging, Inc. develops diagnostic imaging equipment. It also offers tool workflow management software. The firm solutions include private practice and health subsystems. The company was founded by Chris Wood in 2005 and is headquartered in Seattle, WA.	Health Technology
Dendreon Corp. Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.	Health Technology